HEOR ​/ HTA Specialist

Salary Range: €36,200.00 - €67,200.00

#LI-Hybrid The HEOR HTA Specialist position prepares product access strategy by providing state of the art and updated evidence from quality health economics, outcomes research, patient reported outcomes and RWE based perspective across designed products life cycle. The main objective of this propose is to obtain and maintain national/ regional / local access to patient needs, evaluative bodies, decision makers’ requirements and NVS product objectives.

Be able to develop trustful based relationships with HTA and evaluation bodies, to position NVS as a preferred partner in evidence development and presentation processes to reach optimal market access conditions for Patients, Health Care system and NVS. Contribute with Early Access & HEOR Lead and Pricing department for achieving best P&R conditions in a timely manner, analyzing market and competitor’s environment and analogs benchmark, plus taking into consideration customer’s insights.

Develop high quality P&R negotiations tools aligned with the brand strategy (added value dossiers, HE models, budget impact and others health economic data) and support the overall negotiations process preparing high quality and fast answers for evaluation bodies questions and challenges. HEOR competitive intelligence:
Capturing insights from different stakeholders about disease management, product competitors, processes, pathways funding, to capture and anticipate opportunities or barriers affecting in product objectives. Incorporate HEOR and access needs perspective to ensure best product positioning inside Integrated Product Evidence plans for any new product or prioritized new indication among NVS products pipeline. Collaborate in the development of Integrated Product Plans by ensuring that potential important evidence requirements are taken into consideration to overcome product evaluation requirements.

Provide accurate and timely feedback to Region Europe, IM & Global when requested. Prepare Product Access plan as part of IPS in collaboration with the other Market access Team. Project management for generate and customize health economics evidence and tools for evaluative bodies and budget holders and for other MA team functions (RAMs, KAMs etc.) To ensure the development of high-quality real-world evidence studies to support NVS product value in real practice scenarios in collaboration with internal and external stakeholders, along the different HEOR areas of expertise, (i.e:
Health economics, - Patient Reported Outcomes Burden of Disease and health care resources utilizations studies, patient preferences, etc) To provide accurate and valuable insights to Early product shaping and potential positioning strategy from a Spanish access perspective in collaboration with our Early products colleagues for designed products and assets.

Bachelor or superior degree in Health, Biological Sciences or Social/ Economical Sciences Specialization (master’s degree in health economics & policy, or Clinical/ Medical Sciences) Desirable Postgraduate degree in Clinical Sciences (Valuable), Postgraduate degree in Pharmaceutical Industry Management (Valuable) or PhD in Sciences, Health Care Management or Epidemiology From 1 to 3 years of experience in pharmaceutical industry in similar position, in other positions related to drug evaluation, approval and reimbursement processes, and key NVS therapeutic areas knowledge and value demonstration activities.

Market and customer intelligence Strong analytical, strategic, and scenario-planning capabilities to support access decision making. Learning agility, resilience, and ability to operate effectively under ambiguity and changing external conditions.

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen. Expected Annual Base Salary Range for role: 36,200.

-…